Patient‐reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer
Ronald C. Chen(University of North Carolina at Chapel Hill), Theodore S. Hong(Massachusetts General Hospital), Harvey J. Mamon(Brigham and Women's Hospital), James A. Talcott(ImmunityBio (United States)), Jeffrey W. Clark(Massachusetts General Hospital), Yu‐Hui Chen(Dana-Farber Cancer Institute), W. Warren Suh(University of California, Santa Barbara), Rebecca Gelman(Dana-Farber Cancer Institute)
Cited by 31
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k